Salm Partners, LLC, Recalls Johnsonville Polish Kielbasa Turkey Sausage Products

Due to Possible Foreign Matter Contamination

Translate to Spanish or other 102 languages!

Salm Partners, LLC, a Denmark, Wis., establishment, is recalling approximately 35,430 pounds of Johnsonville turkey kielbasa sausage that may be contaminated with foreign materials, specifically pieces of rubber, the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) announced. Image for illustration purposes
Salm Partners, LLC, a Denmark, Wis., establishment, is recalling approximately 35,430 pounds of Johnsonville turkey kielbasa sausage that may be contaminated with foreign materials, specifically pieces of rubber, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced. Image for illustration purposes
- Advertisement -

USDA Food Safety and Inspection Services

WASHINGTON, DC- Salm Partners, LLC, a Denmark, Wis., establishment, is recalling approximately 35,430 pounds of Johnsonville turkey kielbasa sausage that may be contaminated with foreign materials, specifically pieces of rubber, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced.

The turkey kielbasa sausages were produced between Oct. 30-31, 2023. The following products are subject to recall [view labels]:

- Advertisement -
  • 12-oz. vacuum-packed packages containing a single piece of “Johnsonville POLISH KIELBASA TURKEY” sausage and best by dates “05/17/24” and “05/18/24” printed on the side of the packaging.

The products subject to recall bear establishment number “P-32009” printed on the side of the packaging. These items were shipped to retail locations nationwide.

The problem was discovered after the firm received complaints from consumers reporting they found pieces of rubber in the ready-to-eat turkey kielbasa products.

There have been no confirmed reports of adverse reactions or injury due to consumption of these products. Anyone concerned about an injury should contact a healthcare provider.

FSIS is concerned that some product may be in consumers’ refrigerators. Consumers who have purchased these products are urged not to consume them. These products should be thrown away or returned to the place of purchase.

- Advertisement -

FSIS routinely conducts recall effectiveness checks to verify recalling firms notify theircustomers of the recall and that steps are taken to make certain that the product is no longer available to consumers. When available, the retail distribution list(s) will be posted on the FSIS website at www.fsis.usda.gov/recalls.

Consumers and members of the media with questions about the recall can contact Stephanie Schafer, Director of Global Corporate Communications for Johnsonville, at 888-556-2728 or sschafer@johnsonville.com.

Consumers with food safety questions can call the toll-free USDA Meat and Poultry Hotline at 888-MPHotline (888-674-6854) or send a question via email to MPHotline@usda.gov. For consumers that need to report a problem with a meat, poultry, or egg product, the online Electronic Consumer Complaint Monitoring System can be accessed 24 hours a day at https://foodcomplaint.fsis.usda.gov/eCCF/.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study: Weight Loss Drugs Cut Risk of Four Cancers by Half or More

Medical News Today The use of glucagon-like peptide-1 (GLP-1) receptor agonistTrusted Source medications continues...

Summer Readiness: Keep Your Family Safe with These Heat Tips

The National Weather Service has several tips and warnings with summer temperatures hitting well over the 100-degree mark.

DHR Health To Host 20th Annual “Fishing for Hope” Tournament, August 22nd

DHR Health invites the community to cast a line for a cause at its 20th Annual Fishing for Hope Tournament. The event is set for August 22, 2026, at Jim’s Pier on South Padre Island.

FDA Approves Expanded Use of Kidney Cancer Treatment Rooted in UTSW Discovery

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug. This move marks the latest expansion of belzutifan’s indications after it was originally approved in 2021.
- Advertisement -